{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:17:48Z","timestamp":1783498668988,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903154"],"award-info":[{"award-number":["81903154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China Postdoctoral Science Foundation Funded Project","award":["2022M711722"],"award-info":[{"award-number":["2022M711722"]}]},{"name":"grants from Jiangsu Provincial Research Hospital","award":["YJXYY202204"],"award-info":[{"award-number":["YJXYY202204"]}]},{"name":"grants from the Nantong Health Commission Project","award":["QN2023007"],"award-info":[{"award-number":["QN2023007"]}]},{"name":"Clinical Medicine Research Project of Nantong University","award":["2024LZ026"],"award-info":[{"award-number":["2024LZ026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Aplastic anemia (AA) is a severe hematological disorder caused by hyperactivated T cell-mediated hematopoietic failure. It is characterized by hematopoietic stem cell deficiency and hypocellular hematopoiesis in the bone marrow (BM). Ferroptosis, a specific type of programmed cell death, is defined by iron-dependent lipid peroxidation, which has garnered the attention of researchers due to its unique role and biological importance in various diseases. However, the correlation between immunological imbalance-induced ferroptosis and the mortality of hematopoietic stem cells within the BM microenvironment in AA is unclear. Resveratrol (RSV) is crucial in activating NRF2, hence influencing the onset and progression of diseases by regulating ferroptosis. This study aimed to investigate the roles and molecular mechanisms of RSV in the hematopoietic recovery of AA regarding ferroptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We measured some biomarkers in AA mice and IFN-gamma-treated 32D cells, representing AA syndromes and ferroptosis features. Furthermore, in RSV-treated 32D AA cells, cell activity, cell apoptosis, mitochondrial membrane potential, mitochondrial membrane permeability, and intracellular levels of MDA, ferrous iron, 4-HNE, GSH, ROS, and lipid peroxidation were assessed. Subsequently, additional in vitro and in vivo experiments were performed to investigate the mechanisms by which RSV effectively regulates NRF2 stability, further inhibiting ferroptosis in AA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We demonstrated that ferroptosis contributes to the occurrence and development of AA disease. RSV dose-dependently inhibits ferroptosis in 32D AA cells by targeting GPX4 expression, enhancing the cell activity of hematopoietic BM cells. Mechanically, RSV significantly increases NRF2 phosphorylation through the PI3K\/AKT\/mTOR signaling pathway, which maintains NRF2 stability to promote the GPX4 metabolic pathway in AA. Protein levels of p-AKT, p-mTOR, p-NRF2, and GPX4 were markedly increased in BM cells in RSV-treated AA mice, resulting in the suppression of AA development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our data demonstrate that RSV effectively inhibits ferroptosis in AA or IFN-gamma-treated 32D cells by targeting the PI3K\/AKT\/mTOR signaling pathway, which enhances NRF2-mediated GPX4 transcription, thereby ameliorating AA symptoms in vitro and in vivo. This study concludes that RSV is a potential therapeutic drug for ferroptosis-related AA treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01462-5","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:35:15Z","timestamp":1783492515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resveratrol-activated PI3K\/AKT\/mTOR signaling pathway attenuates ferroptosis by promoting NRF2\/GPX4 metabolic pathway to mitigate IFN-gamma-mediated aplastic anemia"],"prefix":"10.1186","volume":"21","author":[{"given":"Erhao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"17","key":"1462_CR1","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra1413485","volume":"379","author":"NS Young","year":"2018","unstructured":"Young NS. Aplastic anemia. N Engl J Med. 2018;379(17):1643\u201356.","journal-title":"N Engl J Med"},{"issue":"4","key":"1462_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/bjh.14510","volume":"177","author":"N Stanley","year":"2017","unstructured":"Stanley N, Olson TS, Babushok DV. Recent advances in understanding clonal haematopoiesis in aplastic anaemia. Br J Haematol. 2017;177(4):509\u201325.","journal-title":"Br J Haematol"},{"issue":"8","key":"1462_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1182\/blood.2025029791","volume":"146","author":"PM Brunner","year":"2025","unstructured":"Brunner PM. The landscape of disease: mapping aplastic anemia. Blood. 2025;146(8):905\u20136.","journal-title":"Blood"},{"issue":"8","key":"1462_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1182\/blood.2025028723","volume":"146","author":"ES Pool","year":"2025","unstructured":"Pool ES, Luk SJ, Ijsselsteijn ME, van Unen V, de Miranda NFCC, Falkenburg JHF, et al. Imaging mass cytometry reveals the order of events in the pathogenesis of immune-mediated aplastic anemia. Blood. 2025;146(8):951\u201363.","journal-title":"Blood"},{"issue":"6","key":"1462_CR5","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s41375-023-01892-2","volume":"37","author":"RP Gale","year":"2023","unstructured":"Gale RP, Hinterberger W, Young NS, Gennery AR, Dvorak CC, Hebert KM, et al. What causes aplastic anaemia? Leukemia. 2023;37(6):1191\u20133.","journal-title":"Leukemia"},{"issue":"787","key":"1462_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl6758","volume":"17","author":"S Lundgren","year":"2025","unstructured":"Lundgren S, Huuhtanen J, Ker\u00e4nen M, Feng X, Patel BA, Ryland GL, et al. Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8+T cells with a disease-associated TCR signature. Sci Transl Med. 2025;17(787):eadl6758.","journal-title":"Sci Transl Med"},{"issue":"14","key":"1462_CR7","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood.2023023142","volume":"143","author":"A Ben Hamza","year":"2024","unstructured":"Ben Hamza A, Welters C, Stadler S, Br\u00fcggemann M, Dietze K, Brauns O, et al. Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry. Blood. 2024;143(14):1365\u201378.","journal-title":"Blood"},{"issue":"5","key":"1462_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13265","volume":"97","author":"M Gao","year":"2023","unstructured":"Gao M, Zhang D, Xu R. Advances in understanding the role of dendritic cells in aplastic anaemia. Scand J Immunol. 2023;97(5):e13265.","journal-title":"Scand J Immunol"},{"issue":"11","key":"1462_CR9","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1038\/s41375-021-01219-z","volume":"35","author":"AN Seyfried","year":"2021","unstructured":"Seyfried AN, McCabe A, Smith JNP, Calvi LM, MacNamara KC. CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia. Leukemia. 2021;35(11):3139\u201351.","journal-title":"Leukemia"},{"key":"1462_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1552000","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhong H. The absolute number of T lymphocyte subsets is beneficial for differential diagnosis of myelodysplastic syndrome with pure red cell aplastic anemia: a case report and review of the literature. Front Immunol. 2025;16:1552000.","journal-title":"Front Immunol"},{"issue":"6","key":"1462_CR11","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/s41375-025-02595-6","volume":"39","author":"R Takahashi","year":"2025","unstructured":"Takahashi R, Takahashi H, Seoka L, Iwasaki H, Takamatsu H, Imi T, et al. Interferon-\u03b3-mediated selective inhibition of hematopoiesis and the clonal advantage of HLA-lacking hematopoietic stem progenitor cells in aplastic anemia. Leukemia. 2025;39(6):1490\u2013502.","journal-title":"Leukemia"},{"issue":"16","key":"1462_CR12","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1182\/blood-2014-04-568451","volume":"124","author":"AM de Bruin","year":"2014","unstructured":"de Bruin AM, Voermans C, Nolte MA. Impact of interferon-\u03b3 on hematopoiesis. Blood. 2014;124(16):2479\u201386.","journal-title":"Blood"},{"issue":"24","key":"1462_CR13","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1182\/blood-2015-06-652453","volume":"126","author":"J Chen","year":"2015","unstructured":"Chen J, Feng X, Desierto MJ, Keyvanfar K, Young NS. IFN-\u03b3-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure. Blood. 2015;126(24):2621\u201331.","journal-title":"Blood"},{"issue":"3","key":"1462_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/jcsm.13449","volume":"15","author":"D Chen","year":"2024","unstructured":"Chen D, Yuan Z, Guo Y, Liu W, Cheng Z, Ye L, et al. The evolution and impact of sarcopenia in severe aplastic anaemia survivors following allogeneic haematopoietic cell transplantation. J Cachexia Sarcopenia Muscle. 2024;15(3):1094\u2013107.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"1462_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01324-1","volume":"15","author":"L Liu","year":"2022","unstructured":"Liu L, Lei M, Fu R, Han B, Zhao X, Liu R, et al. Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study. J Hematol Oncol. 2022;15(1):105.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"1462_CR16","first-page":"1693","volume":"110","author":"JH Oved","year":"2025","unstructured":"Oved JH, Bacigalupo A, DeZern AE. Towards graft-versus-host disease-free alternative donor transplant platforms for patients with acquired aplastic anemia. Haematologica. 2025;110(8):1693\u2013701.","journal-title":"Haematologica"},{"issue":"3","key":"1462_CR17","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/bjh.19648","volume":"205","author":"A Prabahran","year":"2024","unstructured":"Prabahran A, Durrani J, Coelho-Da Silva J, Shalhoub R, Lotter J, Rios O, et al. Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia. Br J Haematol. 2024;205(3):1170\u20139.","journal-title":"Br J Haematol"},{"issue":"2","key":"1462_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1182\/blood-2011-05-352328","volume":"119","author":"P Scheinberg","year":"2012","unstructured":"Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Wu CO, Young NS. Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia. Blood. 2012;119(2):345\u201354.","journal-title":"Blood"},{"issue":"6","key":"1462_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25(6):424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"1462_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"1462_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110131","volume":"118","author":"W Liu","year":"2023","unstructured":"Liu W, Tan Z, Zhao Y, Zhao Y, Yu X, Wang B, et al. Panaxadiol saponin ameliorates ferroptosis in iron-overload aplastic anemia mice and Meg-01 cells by activating Nrf2\/HO-1 and PI3K\/AKT\/mTOR signaling pathway. Int Immunopharmacol. 2023;118:110131.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"1462_CR22","doi-asserted-by":"publisher","first-page":"9723","DOI":"10.1021\/acs.jmedchem.5c00546","volume":"68","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Ma X, Pan W, Li X, Li Y, Fang N, et al. A novel compound 3a\u2013M1, from metabolites of sinomenine derivative 3a, exerts potent anti-aplastic anemia activity via IP3R\/ORAI-mediated CTL ferroptosis. J Med Chem. 2025;68(9):9723\u201340.","journal-title":"J Med Chem"},{"issue":"1","key":"1462_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/pharmaceutics17010134","volume":"17","author":"L Radeva","year":"2025","unstructured":"Radeva L, Yoncheva K. Resveratrol-a promising therapeutic agent with problematic properties. Pharmaceutics. 2025;17(1):134.","journal-title":"Pharmaceutics"},{"key":"1462_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1408651","volume":"11","author":"X Yu","year":"2024","unstructured":"Yu X, Jia Y, Ren F. Multidimensional biological activities of resveratrol and its prospects and challenges in the health field. Front Nutr. 2024;11:1408651.","journal-title":"Front Nutr"},{"key":"1462_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1473939","volume":"15","author":"L Peng","year":"2024","unstructured":"Peng L, Hu XZ, Liu ZQ, Liu WK, Huang Q, Wen Y. Therapeutic potential of resveratrol through ferroptosis modulation: insights and future directions in disease therapeutics. Front Pharmacol. 2024;15:1473939.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1462_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.18632\/aging.101361","volume":"10","author":"EN Kim","year":"2018","unstructured":"Kim EN, Lim JH, Kim MY, Ban TH, Jang IA, Yoon HE, et al. Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury. Aging. 2018;10(1):83\u201399.","journal-title":"Aging"},{"issue":"6","key":"1462_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-025-01145-0","volume":"24","author":"DD Zhang","year":"2025","unstructured":"Zhang DD. Thirty years of NRF2: advances and therapeutic challenges. Nat Rev Drug Discov. 2025;24(6):421\u201344.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1462_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107\u201325.","journal-title":"Cell Res"},{"issue":"8","key":"1462_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.tips.2024.05.006","volume":"45","author":"J Liu","year":"2024","unstructured":"Liu J, Tang D, Kang R. Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges. Trends Pharmacol Sci. 2024;45(8):666\u201370.","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"1462_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nm.3821","volume":"21","author":"CD C\u00f4t\u00e9","year":"2015","unstructured":"C\u00f4t\u00e9 CD, Rasmussen BA, Duca FA, Zadeh-Tahmasebi M, Baur JA, Daljeet M, et al. Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network. Nat Med. 2015;21(5):498\u2013505.","journal-title":"Nat Med"},{"issue":"7","key":"1462_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41419-022-05080-5","volume":"13","author":"Y Qu","year":"2022","unstructured":"Qu Y, Sun Z, Yuan Y, Li Z, Wang F, Wu K, et al. Monocytic myeloid-derived suppressive cells mitigate over-adipogenesis of bone marrow microenvironment in aplastic anemia by inhibiting CD8+ T cells. Cell Death Dis. 2022;13(7):620.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1462_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","volume":"133","author":"G Weiss","year":"2019","unstructured":"Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40\u201350.","journal-title":"Blood"},{"issue":"11","key":"1462_CR33","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jama.2024.15196","volume":"332","author":"WK Nicholson","year":"2024","unstructured":"Nicholson WK, Silverstein M, Wong JB, Chelmow D, Coker TR, Davis EM, et al. Screening and supplementation for iron deficiency and iron deficiency anemia during pregnancy: US preventive services task force recommendation statement. JAMA. 2024;332(11):906\u201313.","journal-title":"JAMA"},{"issue":"1","key":"1462_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-024-02088-5","volume":"10","author":"F Alves","year":"2025","unstructured":"Alves F, Lane D, Nguyen TPM, Bush AI, Ayton S. In defence of ferroptosis. Signal Transduct Target Ther. 2025;10(1):2.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"1462_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307022","volume":"11","author":"Y Yu","year":"2024","unstructured":"Yu Y, Su Y, Yang S, Liu Y, Lin Z, Das NK, et al. Activation of intestinal HIF2\u03b1 ameliorates iron-refractory anemia. Adv Sci. 2024;11(12):e2307022.","journal-title":"Adv Sci"},{"issue":"12","key":"1462_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306571","volume":"11","author":"P Xiao","year":"2024","unstructured":"Xiao P, Cai X, Zhang Z, Guo K, Ke Y, Hu Z, et al. Butyrate prevents the pathogenic anemia-inflammation circuit by facilitating macrophage iron export. Adv Sci. 2024;11(12):e2306571.","journal-title":"Adv Sci"},{"issue":"2","key":"1462_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202102669","volume":"9","author":"Z Lu","year":"2022","unstructured":"Lu Z, Huang L, Li Y, Xu Y, Zhang R, Zhou Q, et al. Fine-tuning of cholesterol homeostasis controls erythroid differentiation. Adv Sci. 2022;9(2):e2102669.","journal-title":"Adv Sci"},{"issue":"4","key":"1462_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, et al. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40(4):365-78.e6.","journal-title":"Cancer Cell"},{"key":"1462_CR39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2023.05.027","volume":"205","author":"T Cao","year":"2023","unstructured":"Cao T, Zhou J, Liu Q, Mao T, Chen B, Wu Q, et al. Interferon-\u03b3 induces salivary gland epithelial cell ferroptosis in Sjogren\u2019s syndrome via JAK\/STAT1-mediated inhibition of system Xc. Free Radic Biol Med. 2023;205:116\u201328.","journal-title":"Free Radic Biol Med"},{"key":"1462_CR40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.freeradbiomed.2025.04.052","volume":"235","author":"E Zhang","year":"2025","unstructured":"Zhang E, Wang Y, Zhang H, Li X, Su Y, Cui J, et al. Resveratrol induces ferroptosis in triple-negative breast cancer through NEDD4L-mediated GPX4 ubiquitination and degradation. Free Radic Biol Med. 2025;235:231\u201347.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1462_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10020-023-00730-6","volume":"29","author":"X Wang","year":"2023","unstructured":"Wang X, Shen T, Lian J, Deng K, Qu C, Li E, et al. Resveratrol reduces ROS-induced ferroptosis by activating SIRT3 and compensating the GSH\/GPX4 pathway. Mol Med. 2023;29(1):137.","journal-title":"Mol Med"},{"key":"1462_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2024.111136","volume":"220","author":"C Li","year":"2025","unstructured":"Li C, Ge H, Huang J, Si L, Sun L, Wu L, et al. Resveratrol alleviates depression-like behaviors by inhibiting ferroptosis via AKT\/NRF2 pathway. Brain Res Bull. 2025;220:111136.","journal-title":"Brain Res Bull"},{"issue":"10","key":"1462_CR43","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/jemt.24335","volume":"86","author":"C Ni","year":"2023","unstructured":"Ni C, Ye Q, Mi X, Jiao D, Zhang S, Cheng R, et al. Resveratrol inhibits ferroptosis via activating NRF2\/GPX4 pathway in mice with spinal cord injury. Microsc Res Tech. 2023;86(10):1378\u201390.","journal-title":"Microsc Res Tech"},{"issue":"20","key":"1462_CR44","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1111\/jcmm.17874","volume":"27","author":"W Zhang","year":"2023","unstructured":"Zhang W, Qian S, Tang B, Kang P, Zhang H, Shi C. Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1\/p53 pathway activation. J Cell Mol Med. 2023;27(20):3075\u201389.","journal-title":"J Cell Mol Med"},{"key":"1462_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.freeradbiomed.2012.10.530","volume":"54","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhai Z, Wang Y, Zhang J, Wu H, Wang Y, et al. Resveratrol ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic Biol Med. 2025;54:40\u201350.","journal-title":"Free Radic Biol Med"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01462-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01462-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01462-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:03:25Z","timestamp":1783497805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01462-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1462"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01462-5","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human research was conducted in accordance with ethical standards and the Declaration of Helsinki, with approval from the institutional review board of affiliated hospital of Nantong University (approve No. 2024-L773; date: 29 July 2024). All patients submitted written informed consent prior to analysis. The animal study of the current study was performed in accordance with the Basel Declaration and approved by the Animal Ethics Committee of Nantong University (approval No. S20240729-053; date: 29 July 2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}